FermCo, Inc.

FermCo, Inc.

Open Source Fermentation Solution BIO World Congress, July 21, 2015

 

 

BioEconomy Partners, LLC

Lagging  Renewable  Infrastructure  Investment    in  Biobased  Segment  

“From  2004  through  2010,  the  compound  annual  growth  rate  of  total  new  investment  clocked  in  at  36  percent.”  

Gap  in  Manufacturing  Capability  

RESEARCH/ INTELLECTUAL

PROPERTY

PROOF OF CONCEPT

PROTOTYPING, BETA

MANUFACTURING

DEEPER CAPITAL

INVESTMENT

MARKET EXPANSION

•  PotenLal  to  add  $230B  to  the  global  economy  by  2020,    (World  Economic  Forum)    

2

0

0

7

1

0

2

North America 390K L +/-

0

South America 0

0

Africa 0

7

Europe 5.2M L +/-

1

Asia 1.6M L +/-

0

Australia 0

Weak  Link  in  the  Value  Chain:    Readily  Available  Toll  FermentaLon  

Global  Capacity  Today  =  7.1M  Ltrs  

FermCo,  Inc.  Toll  FermentaLon    2.1M  Liters    

  Customers:    •  Biotechnology  scale  up  •  Biotechnology  licensors  •  AddiLonal  IP  development  scale  up  •  Large  players  with  biotechnology  partners  •  Downstream  partners  for  supply  assurance  

 FermCo,  Inc  will  provide  28%  of  the  global  capacity  for    readily  available  fermentaLon      

BioEconomy Partners

Global  Foundaries:  Growth  of  an  Industrial    Semiconductor  Ecosystem  

•  4.2B  CAPEX  •  1.2B  Gov  ContribuLon  •  Over  5,000  jobs  •  Key  Infrastructure  •  SUNY  College  of  Nano              Scale  Science  and  Engineering  

TECH  HUB  

 

•  2,000,000  liter  general  purpose  facility  •  6  @  320,000  liter  fermenters  •  3    @  train  of    5,000  &    40,000  liters  •  28,500  man  hours  of  labor  

•  Biotechnology  licensors  •  Biotechnology  scale  up  •  AddiLonal  IP  scale  up  •  Large  players  with  biotechnology  partners  •  Downstream  partners  for  supply  assurance  

FermCo,  Inc.  Toll  FermentaLon    2.1M  Liters    

BioEconomy Partners

A  FermentaLon  Company  with  a  Flexible  ProducLon  System  for  customers  to  reduce  risk  in  the  supply  chain.      •  Robust  service  model    •  Assignable  Priority  ProducLon  Right    

•  ProducLon  within  30-­‐60  days  •  Can  be  licensed  to  other  companies  or  

strategic  partners,  or  even  sold  if  not  needed  

•  LEED  CerLfied  Plant  •  Advantaged  site  -­‐  with  co-­‐locaLon  for  

downstream  •  Constructed  with  a  cooperaLve  input  process  •  Phased  investment  lowers  risk  •  Can  be  leveraged  with  downstream  partners  

FermCo,  Inc.    Dedicated  cost  effecLve  fermentaLon  

 

Biobased  Technology  Companies  Face  the    Magnitude  of  Scale  Up  and  CAPEX  Hurdles  

For  Customers  ContracLng  The  Core  Technology:  FermentaLon  

 •  Reduces  Capex  •  Provides  Supply  Security;  

Increases  Sales  to  Market  •  Expedites  Commercial  Scale  

QuanLLes  •  Provides  a  “Plug  and  Play”  

Answer  to  Core  Infrastructure  Needs  for  Pilot  and  Commercial  ProducLon.    

•  Customer  Companies  can  then  Focus  on  their  Company’s  Special  Sauce  /  Black  Box  

•  Reduces  Capital  Raise  Needs    Bo#om  Line:  Increases  compe11veness  and  creates  a  cost  advantaged  commercializa1on  plan  

BioEconomy Partners

FermentaLon  takes  a  large  porLon  of  scale  up  off  their  plate.    

   Efficiencies  Gained  Through  Site  SelecLon:      Eastman  Business  Park  Rochester,  NY    

BioEconomy Partners

CP

EPCM

GOV

Customer-­‐Partners  

Site

Developer

Flex Facility - Core

Public Partner

Paradigm  Shio:    the  FermCo,  Inc.    Model  

BioEconomy Partners

FermCo  Inc.  Holding  Company    

               

                                               Toll  Fermenta1on      

Project  EnLty  CAPEX  $42M  

FermCo  Inc.                    

                 Bioscience  Manufacturing  Center    

Project  EnLty  CAPEX  $42M  

Non-­‐Dilu1ve  Equity  

FermCo,  Inc.  Investment  Model  

Return  

EPCM  Engineering  Procurement  ConstrucLon  Management  

OPERATIONS  Salaried  Employees,  Management,  AdministraLon,  AssociaLon  Fees  

BioEconomy  Partners    

Equity      

Strategic  Investors          

Strategic  Investor  /  Customer      

    Debt  

InsLtuLonal  Investors  

Strategic  Investor  /  Customer  

BioEconomy Partners

FermCo  Inc.                    

                 Bioscience  Manufacturing  Center    

Project  EnLty  CAPEX  $42M  

Non-­‐Dilu1ve  Equity  

FermCo,  Inc.  Investments  Confirmed  

EPCM  Engineering  Procurement  ConstrucLon  Management  

OPERATIONS  Salaried  Employees,  Management,  AdministraLon,  AssociaLon  Fees  

BioEconomy  Partners    

Equity      

Strategic  Seed  Investor  

Strategic  Investor  /  Customer      

    Debt  

InsLtuLonal  Investors  

Strategic  Investor  /  Customer    

BioEconomy Partners

✔    

✔    ✔    

✔    

✔    

✔    

✔    

Contact:  Ally  LaTourelle,  Esq.    Ally.latourelle@bioecnomypartners.com  P.  917-­‐428-­‐6008  www.bioeconomypartners.com  Skype:    ally.latourelle  

 The  informa1on  contained  herein  is  of  a  general  nature  and  is  not  intended  to  address  the  circumstances  of  any  par1cular  individual  or  en1ty.  Although  we  endeavor  to  provide  accurate  and  1mely  informa1on,  there  can  be  no  guarantee  that  such  informa1on  is  accurate  as  of  the  date  it  is  received  or  that  it  will  con1nue  to  be  accurate  in  the  future.  No  one  should  act  upon  such  informa1on  without  appropriate  professional  advice  a=er  a  thorough  examina1on  of  the  par1cular  situa1on.    

   

BioEconomy Partners

   

           

 The  right  knowledge  and    the  right  relaLonships    

at  the  right  Lme.    

-­‐  ConfidenLal  -­‐